Armodafinil Treatment as Adjunctive Therapy in Adults With Major Depression Associated With Bipolar I Disorder
Completed · Phase 2 · Has a placebo group
Conditions studied: Bipolar I Depression
In brief
The primary objective of the study is to determine if armodafinil treatment, at a dosage of 150 mg/day, is more effective than placebo treatment as adjunctive therapy for adults who are experiencing a major depressive episode associated with Bipolar I Disorder and who are inadequately responsive to their current treatment for a current major depressive episode.
Key facts
- Study ID
- NCT00481195
- Run by
- Cephalon
- People needed
- 257
- Starts
- 2007-06-01
- Expected to finish
- 2008-12-01
- Last updated by the study team
- 2013-07-19
Who can join
Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Birmingham Psychiatry Pharmaceutical Studies, Inc — Birmingham, Alabama, United States
- Synergy Clinical Research Center — Escondido, California, United States
- Bay Area Research Institute — Lafayette, California, United States
- Synergy Clinical Research Center — National City, California, United States
- Excell Research — Oceanside, California, United States
- Pacific Clinical Research Medical Group — Orange, California, United States
- CNRI Los Angeles LLC — Pico Rivera, California, United States
- Pacific Clinical Research Medical Group — Riverside, California, United States
- California Neuropsychopharmacology Clinical Research Inst — San Diego, California, United States
- Stanford University — Stanford, California, United States
- Clinical Neuroscience Solutions Inc — Jacksonville, Florida, United States
- Fidelity Clinical Research — Lauderhill, Florida, United States
- Stedman Clinical Trials, LLC — Tampa, Florida, United States
- Janus Center for Psychiatric Research — West Palm Beach, Florida, United States
- Atlanta Center for Clinical Research — Atlanta, Georgia, United States
- Carman Research — Smyrna, Georgia, United States
- Psychiatric Medicine Associates — Skokie, Illinois, United States
- Capital Clinical Research Associates — Rockville, Maryland, United States
- CNS Research Institute — Clementon, New Jersey, United States
- Behavioral Medical Research of Brooklyn — Brooklyn, New York, United States
- Social Psychiatry Research Institute — Brooklyn, New York, United States
- Social Psychiatry Research Institute — New York, New York, United States
- Medical & Behavioral Health Research — New York, New York, United States
- Behavioral Medical Research of Staten Island — Staten Island, New York, United States
- Birmingham Research Group — Birmingham, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.